CCK-8 assay results also showed that knocking down CDK6 gene expression could significantly reduce the IC50 of cisplatin in bladder cancer cells that were elevated due to over-expression of IGF2BP3 (Figure 7F and Figure S6F). The gene discussed is IGF2BP3; the disease is urinary bladder cancer.